Virgo and CTNx Partner to Power GI Clinical Trials
Virgo Surgical Video Solutions, Inc. (“Virgo”) and The Clinical Trials Network (“CTNx”) have today announced a strategic partnership to expand and accelerate the identification, selection, and enrollment of patients in gastrointestinal (GI) clinical trials across CTNx’s expansive network of 30+ GI clinical trial sites, using Virgo’s endoscopy data capture and artificial intelligence platform. Virgo and CTNx is an exciting partnership!
The Clinical Trials Network brings physicians together to create a leading source of high-quality research sites to present to trial sponsors. Virgo’s cloud-based, HIPAA- and SOC-2-compliant platform allows gastroenterologists to automatically record, store, and manage endoscopy videos without interrupting clinical workflows. Artificial intelligence tools developed by Virgo analyze complex inclusion and exclusion criteria set forth by trial sponsors, ultimately making clinical trials more accessible to a larger, more diverse set of patients suffering from GI conditions such as Ulcerative Colitis and Crohn’s Disease.
“We feel honored to be working with the CTNx team. We are both impressed by their network and excited to deploy our cloud-based products to their membership in pursuit of greater access, equity, and inclusion in GI clinical trials,” said Ian Strug, Co-founder and Chief Revenue Officer of Virgo. “We believe this partnership will yield heightened study opportunities across a broad spectrum of diseases and device trials, in addition to adding standard of care capabilities to the everyday work of patient care.”
“We are beyond excited to be working with the Virgo team and their best-in-class AI GI technology,” said Keith Friedenberg, CEO of CTNx. “We feel this partnership is an exciting moment for the future of clinical trial recruitment. This accelerates our mission of bringing clinical trials to community physicians and their patients.”
About Virgo
Virgo Surgical Video Solutions provides the leading cloud video capture, management, and artificial intelligence analysis platform for endoscopic medicine. Over 80 academic, integrated, and private practice healthcare providers use Virgo’s HIPAA- and SOC-2-compliant platform to advance patient care through video-based research and training initiatives. In 2021, Virgo launched a suite of tools called Virgo Trials, which help pharmaceutical trial sponsors and their participating trial sites accelerate patient recruitment and shorten the overall enrollment period for trials. For more information, visit virgosvs.com.
About CTNx
The Clinical Trials Network (CTNx) is a specialty-based network of private practice research sites dedicated to expanding access and representation in clinical trials. Since its inception in 2018, CTNx has opened over 70 sites with networks in Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. CTNx has built its reputation on assisting naïve investigators through the clinical trial space with its fully integrated centralized administrative support and in-house clinical research coordinator identification and training program. For more information, visit www.thectnx.com.